NHS: Supply Chains

(asked on 4th November 2026) - View Source

Question to the Department of Health and Social Care:

To ask His Majesty's Government, with reference to NHS Supply Chain’s proposed move to single national prices for medical technology, whether (1) a business case, (2) an impact assessment covering small and medium-sized enterprises, supply resilience and competition, and (3) a report on consultation with suppliers have been completed; by whom and on what dates each was approved; whether the Competition and Markets Authority has been consulted; and whether they intend to publish any of those documents.


Answered by
Baroness Merron Portrait
Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
This question was answered on 16th November 2026

All framework agreements reaching term commenced before the Procurement Act 2023 and as such are subject to the Public Contracts Regulations 2015 (PCR2015), and any and all notices with respect to extensions beyond the initial term have been published in compliance with PCR2015. Single national pricing already represents the position on 75% of National Health Service spend through the NHS Supply Chain, and further opportunities are being pursued on a category-by-category and case-by-case basis with strategies and engagement of suppliers aligned to each accordingly.

There is no target for reducing the number of products and/or suppliers on NHS Supply Chain frameworks, and in total, the NHS Supply Chain has 145 frameworks, covering a catalogue which today holds 537,003 products supplied by 990 suppliers. Each tender the NHS Supply Chain runs is unique, considers a number of NHS requirements and drivers, including the total cost of delivery and ownership, and where goods and services are bundled together, these are bespoke and evaluated on a case-by-case base.

Reticulating Splines